Effect of earthworm (G-90) extracton formation and lysis of clots originated from venous blood of dogs with cardiopathies and with malignant tumors

Pathology and Oncology Research

Volumn 7, Issue 3, 2001, Pages 197-202

  Popović, Maja ^a   Hrženjak, Terezija Mihaela ^a   Babić, Tomislav ^a   Kos, Josip ^a   Grdiša, Mira ^b  

^a School of Veterinary Medicine   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; GLYCOPROTEIN; STREPTOKINASE; TISSUE EXTRACT;

ANIMAL; ANIMAL DISEASE; ANNELID WORM; ARTICLE; BLOOD; BLOOD CLOTTING TEST; CHEMISTRY; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; DOG; DOG DISEASE; DRUG EFFECT; ERYTHROCYTE; EXPERIMENTAL NEOPLASM; FEMALE; FIBRINOLYSIS; ISOLATION AND PURIFICATION; METABOLISM; VEIN;

ANIMALS; BLOOD COAGULATION TESTS; CARDIOMYOPATHY, DILATED; DOG DISEASES; DOGS; ERYTHROCYTES; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; GLYCOPROTEINS; MAMMARY NEOPLASMS, ANIMAL; OLIGOCHAETA; STREPTOKINASE; TISSUE EXTRACTS; VEINS;

EID: 0035224452     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03032349     Document Type: Article

References (5)

1. Brommer EJP, Emeis JJ, Verheijen JH, et al: Progress in Clinical Fibrinolysis. In: 7 Recent Advances in Blood Coagulation. (Eds. Poller L and Ludlam CA), Churchill Livingstone, 1997, pp 161-182.
2. Gandolfo GM, Conti L, Vercillo M: Fibrinolysis Components as Prognostic Markers in Breast Cancer and Colorectal Carcinoma. Anticancer Res 16:2155-2160, 1992.
3. Glassman A: Hemostatic abnormalities associated with cancer and its therapy. Ann Clini Labo Sci 27:391-395, 1997.
4. Dickneite G, Nicolay U, Friesen HJ, et al: Development of an anti-bleeding agent for recombinant hirudin induced skin bleeding in the pig. Thrombo Haemost 80:192-198, 1998.
5. Du Z, Li X, Qian J, et al: Effect of earthworm fibrinolytic enzyme given orally on the activity of plasmin and on platelet aggregation in beagles dogs. Acta Acade Medi Shang 25:229-231, 1998.